Key result
Adenosine 5'-monophosphate increased cardiac index more than sodium nitroprusside at doses causing similar reductions in systemic vascular resistance index in dogs with acute LV dysfunction.
Why the study?
Does adenosine 5'-monophosphate improve haemodynamic parameters more effectively than sodium nitroprusside in a canine model of acute left ventricular dysfunction?
Does adenosine 5'-monophosphate improve haemodynamic parameters more effectively than sodium nitroprusside in a canine model of acute left ventricular dysfunction?
In a canine model of acute left ventricular dysfunction, AMP provided a more favorable haemodynamic profile than SNP by increasing cardiac index to a greater extent, likely due to more selective arterial vasodilation.
Answers are grounded in this paper and cite their sources.
May support AMP investigation in acute LV dysfunction; leaves open translation from canine models to humans.
The haemodynamic effects of adenosine 5'-monophosphate (AMP) and sodium nitroprusside (SNP) were compared in anaesthetized dogs following the induction of acute left ventricular (LV) dysfunction. 2. LV dysfunction was induced by the intracoronary administration of glass microbeads until left ventricular end diastolic pressure (LVEDP) was increased from 5 to 15 mmHg. This was associated with a decrease in LV dP/dt and cardiac index (CI) of 30% and 27%, respectively, and an increase in systemic vascular resistance index (SVRI) of 37%. 3. Graded doses of AMP (100 to 1000 micrograms kg-1 min-1) or SNP (1 to 10 micrograms kg-1 min-1) reduced SVRI and increased CI in a dose-related manner. Heart rate was not altered by either agent. At doses that caused similar reductions in SVRI, CI was increased more by AMP than by SNP. 4. The mechanisms responsible for the greater elevation of CI by AMP relative to SNP may be related to its more selective arterial vasodilator activity. SNP reduced cardiac preload that limited the expected increase in CI. 5. The haemodynamic profile of AMP suggests that it may be useful in the pharmacological management of acute cardiac failure, either when used alone or in combination with positive inotropic agents and/or selective venodilators.
No takes yet. Share an insight, caveat, or question.
Finegan et al. (1991) studied acute left ventricular dysfunction. adenosine 5'-monophosphate (AMP) vs. sodium nitroprusside (SNP) was evaluated on systemic vascular resistance index (SVRI) and cardiac index (CI). Adenosine 5'-monophosphate increased cardiac index more than sodium nitroprusside at doses causing similar reductions in systemic vascular resistance index in dogs with acute LV dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: